PLUS THERAPEUTICS Inc. (NASDAQ: PSTV)
$1.87
+0.1000 ( +5.65% ) 38.2K
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
Market Data
Open
$1.87
Previous close
$1.77
Volume
38.2K
Market cap
$10.78M
Day range
$1.79 - $1.93
52 week range
$0.97 - $3.21
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Nov 13, 2023 |
4 | Insider transactions | 1 | Nov 08, 2023 |
10-q | Quarterly Reports | 52 | Oct 31, 2023 |
8-k | 8K-related | 13 | Oct 31, 2023 |
8-k | 8K-related | 12 | Oct 31, 2023 |
4 | Insider transactions | 1 | Sep 15, 2023 |
4 | Insider transactions | 1 | Sep 12, 2023 |
8-k | 8K-related | 13 | Aug 14, 2023 |
10-q | Quarterly Reports | 50 | Aug 14, 2023 |